Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Enrolling by invitation · Not applicable

Conditions studied: Group 2 Pulmonary Hypertension, Heart Failure

In brief

This early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension

Key facts

Study ID
NCT06052072
Run by
Gradient Denervation Technologies
People needed
50
Starts
2024-02-20
Expected to finish
2028-07-01
Last updated by the study team
2026-05-19

Who can join

Age: 22 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.